Key points are not available for this paper at this time.
Objective: Continuous Glucose Monitoring (CGM) use in older adults with Type-1 Diabetes (T1D) has shown benefits. However, the impact of CGM use, coupled with simplified treatment regimens and personalized glycemic goals that are better suited for older patients with multiple comorbidities and hypoglycemia, is not known.Research Design and Methods: Older adults (≥65 years) with T1D with hypoglycemia (≥2 episodes of hypoglycemia Results: We randomized 131 participants(age 71±5 years; 21% ≥75 years) to intervention (n=68; CGM-users=33) or control (n=63; CGM-users=40) groups. The median change in hypoglycemia from baseline to 6-months was –2·6% in the intervention group and –0.3% in the control group(median difference –2.3%,95%Cl –3.7%,–1.3%;PConclusions: In older adults with T1D and high risk of hypoglycemia, CGM use enhanced by geriatric principles can lower hypoglycemia without worsening glycemic control in a cost-effective fashion.
Munshi et al. (Thu,) studied this question.